Posts

Summit Touts Updated HARMONi Data Showing Consistent Survival Benefit for Ivonescimab in Western NSCLC Patients

on

SciSparc Subsidiary NeuroThera Labs Gets Conditional TSX Approval for 54% CliniQuantum Acquisition

on

Pfizer and Valneva's Lyme Vaccine Misses Primary Endpoint But Pursue Regulatory Approval

on

Rakuten Medical Raises $100 Million in Oversubscribed Series F for Photoimmunotherapy Platform

on

FluoGuide Strengthens Leadership to Drive Clinical and Regulatory Advancements

on

Metsera Calls Pfizer's Threats 'Nonsense' as Rift Between Companies Widens

on

Dyne Therapeutics' z-rostudirsen Shows Durable Efficacy, Supporting Positive Regulatory Outlook

on

Sirona Medical Receives FDA 510(k) Clearance for Advanced Imaging Suite, Expanding PET-CT and Class II Medical Device Functionality

on

Unlocking Japan's Potential in Rare Disease Drug Development: Recent Progress and Challenges (2025)

on

Recent News: Gain Peace of Mind with the Lentiviral Experts

on

AstraZeneca gears up for FDA filing after baxdrostat's phase 3 hypertension success

on

FDA Delays Decisions on Regeneron’s Eylea HD Due to Manufacturing Issues

on

Novo Nordisk Projects Slower Growth for 2025, Targets CagriSema Approval in 2026

on